M, L., MJ, G., J, C., A, E., M, J., C, P., . . . JA, M. (2023). Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine, 29(3), 632. https://doi.org/10.1038/s41591-022-02178-3
Chicago Style (17th ed.) CitationM, Larrayoz, et al. "Preclinical Models for Prediction of Immunotherapy Outcomes and Immune Evasion Mechanisms in Genetically Heterogeneous Multiple Myeloma." Nature Medicine 29, no. 3 (2023): 632. https://doi.org/10.1038/s41591-022-02178-3.
MLA (9th ed.) CitationM, Larrayoz, et al. "Preclinical Models for Prediction of Immunotherapy Outcomes and Immune Evasion Mechanisms in Genetically Heterogeneous Multiple Myeloma." Nature Medicine, vol. 29, no. 3, 2023, p. 632, https://doi.org/10.1038/s41591-022-02178-3.